Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Willem De Haan
Based on 10 articles published since 2010
(Why 10 articles?)
||||
Expertise Level
The expertise of Willem De Haan ranks in the
  • Top 2%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Aliases de Haan, Willem   ·   De Haan, Willem
Work Locations
Details
Most likely:    Vrije Universiteit Amsterdam      
2020
  • Centre for Discovery Brain Sciences, UK Dementia Research Institute at The University of Edinburgh, Edinburgh, UK. · Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK. · UK Dementia Research Institute at UCL, London, UK. · Cognition Therapeutics. Inc., Pittsburgh, PA, USA. · McKnight Brain Institute, University of Florida, Gainesville, FL, USA. · Alzheimer's Drug Discovery Foundation, New York, NY, USA. · Metis Cognition Ltd, Kilmington, UK. · Alzheimer Center, AUmc, Amsterdam, The Netherlands. · Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. · Keck School of Medicine of USC, Los Angeles, CA, USA. · Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Clinical Neurophysiology and MEG, VU University Medical Center, Amsterdam, Netherlands. · Global R&D Partners, San Diego, CA, USA. · Alzheimer's Disease Research Unit and Departments of Psychiatry, Neurology, and Neuroscience, Yale School of Medicine, New Haven, CT, USA. · Cognition Therapeutics. Inc., Pittsburgh, PA, USA. · Pubmed 32122400
  • Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy; Hospital San Raffaele Cassino, Cassino (FR), Italy. Electronic address: · Faculty of Physics, University of Warsaw and Nalecz Institute of Biocybernetics, Warsaw, Poland. · Department of Neuroscience Imaging and Clinical Sciences and CESI, University G D'Annunzio of Chieti-Pescara, Chieti, Italy. · Skolkovo Institute of Science and Technology (SKOLTECH), Moscow, Russia; Systems Research Institute PAS, Warsaw, Poland; Nicolaus Copernicus University (UMK), Torun, Poland. · Amsterdam Neuroscience, Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. · Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy. · Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, INSERM U1127, Sorbonne Université, Paris, France. · School of Engineering, Institute for Digital Communications, The University of Edinburgh, Edinburgh, UK. · Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain. · IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland. · Department of Biophysics, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey. · Translational Neuropharmacology, Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA. · Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, INSERM U1127, Sorbonne Université, Paris, France; GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, Sorbonne University, Paris, France. · School of Computing, Electronics and Mathematics, Faculty of Science and Engineering, Plymouth University, Plymouth, UK. · School of Psychology, University of Glasgow, Glasgow, UK. · Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. · Mentis Cura ehf, Reykjavík, Iceland. · Department of Bio and Brain Engineering/Program of Brain and Cognitive Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea. · Institute for Neuroscience, Newcastle University, Newcastle upon Tyne, UK. · IRCCS SDN, Napoli, Italy. · Center of Neurosciences, Swammerdam Institute of Life Sciences, University of Amsterdam, Amsterdam, The Netherlands. · School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK. · IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy; Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · UC Davis Department of Neurology, Center for Neuroscience, Davis, CA, USA. · Gladstone Institute of Neurological Disease, San Francisco, CA, USA. · Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland. · IRCCS San Raffaele Pisana, Rome, Italy. · RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan; Graduate School of Education, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; Advanced Center for Computing and Communication, RIKEN, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; Faculty of Physics, The University of Warsaw, Pasteur 5, 02-093 Warsaw, Poland. · A. I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland. · German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic and Psychotherapeutic Medicine, University of Rostock, Rostock, Germany. · Experimental Neuropsychopharmacology, Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Bonn, Germany. · Department of Neurosciences and Department of Neurology, Dokuz Eylül University Medical School, Izmir, Turkey. · Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA. · Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium. · Vertex Pharmaceuticals Incorporated, Boston, MA, USA. · Pubmed 31739167
2017
  • Department of Clinical Neurophysiology and MEG, VUmc, Amsterdam, The Netherlands. · Alzheimer Center and Department of Neurology, VUmc, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Pubmed 28938009
2012
  • Department of Clinical Neurophysiology and MEG, VU University Medical Center, Amsterdam, The Netherlands. · Pubmed 22915996
  • Department of Clinical Neurophysiology and Magnetoencephalography, VU University Medical Center, Amsterdam, The Netherlands. · Pubmed 22480296
2013
  • Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands. · Pubmed 23541878
  • Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, VU University Amsterdam Amsterdam, Netherlands. · Pubmed 24106478
  • Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands. · Pubmed 23587637
  • Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands. · Pubmed 23536835
2012
  • Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands. · Pubmed 22118944
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Willem De Haan in 2010-2020 about Alzheimer Disease:

  • The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease. 2020
  • What electrophysiology tells us about Alzheimer's disease: a window into the synchronization and connectivity of brain neurons. 2020
  • Altering neuronal excitability to preserve network connectivity in a computational model of Alzheimer's disease. 2017
  • Alzheimer's disease: connecting findings from graph theoretical studies of brain networks. 2013
  • Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage. 2013
  • Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity. 2013
  • Single-subject grey matter graphs in Alzheimer's disease. 2013
  • Activity dependent degeneration explains hub vulnerability in Alzheimer's disease. 2012
  • Disruption of functional brain networks in Alzheimer's disease: what can we learn from graph spectral analysis of resting-state magnetoencephalography? 2012
  • Young Alzheimer patients show distinct regional changes of oscillatory brain dynamics. 2012
Show List of Full Article Records
Google Searches

Learn more about Willem De Haan using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Vrije Universiteit Amsterdam
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Vrije Universiteit Amsterdam
2020
  • Centre for Discovery Brain Sciences, UK Dementia Research Institute at The University of Edinburgh, Edinburgh, UK. · Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden. · Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. · Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK. · UK Dementia Research Institute at UCL, London, UK. · Cognition Therapeutics. Inc., Pittsburgh, PA, USA. · McKnight Brain Institute, University of Florida, Gainesville, FL, USA. · Alzheimer's Drug Discovery Foundation, New York, NY, USA. · Metis Cognition Ltd, Kilmington, UK. · Alzheimer Center, AUmc, Amsterdam, The Netherlands. · Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. · Keck School of Medicine of USC, Los Angeles, CA, USA. · Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. · Department of Clinical Neurophysiology and MEG, VU University Medical Center, Amsterdam, Netherlands. · Global R&D Partners, San Diego, CA, USA. · Alzheimer's Disease Research Unit and Departments of Psychiatry, Neurology, and Neuroscience, Yale School of Medicine, New Haven, CT, USA. · Cognition Therapeutics. Inc., Pittsburgh, PA, USA. · Pubmed 32122400
  • Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy; Hospital San Raffaele Cassino, Cassino (FR), Italy. Electronic address: · Faculty of Physics, University of Warsaw and Nalecz Institute of Biocybernetics, Warsaw, Poland. · Department of Neuroscience Imaging and Clinical Sciences and CESI, University G D'Annunzio of Chieti-Pescara, Chieti, Italy. · Skolkovo Institute of Science and Technology (SKOLTECH), Moscow, Russia; Systems Research Institute PAS, Warsaw, Poland; Nicolaus Copernicus University (UMK), Torun, Poland. · Amsterdam Neuroscience, Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. · Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Rome, Italy. · Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, INSERM U1127, Sorbonne Université, Paris, France. · School of Engineering, Institute for Digital Communications, The University of Edinburgh, Edinburgh, UK. · Laboratory of Cognitive and Computational Neuroscience, Center for Biomedical Technology, Universidad Complutense and Universidad Politécnica de Madrid, Madrid, Spain. · IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy; Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland. · Department of Biophysics, International School of Medicine, Istanbul Medipol University, Istanbul, Turkey. · Translational Neuropharmacology, Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA. · Institute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Pitié-Salpêtrière Hospital, AP-HP, Boulevard de l'hôpital, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, INSERM U1127, Sorbonne Université, Paris, France; GRC n° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard de l'hôpital, Sorbonne University, Paris, France. · School of Computing, Electronics and Mathematics, Faculty of Science and Engineering, Plymouth University, Plymouth, UK. · School of Psychology, University of Glasgow, Glasgow, UK. · Geriatric Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. · Mentis Cura ehf, Reykjavík, Iceland. · Department of Bio and Brain Engineering/Program of Brain and Cognitive Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea. · Institute for Neuroscience, Newcastle University, Newcastle upon Tyne, UK. · IRCCS SDN, Napoli, Italy. · Center of Neurosciences, Swammerdam Institute of Life Sciences, University of Amsterdam, Amsterdam, The Netherlands. · School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK. · IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy. · Department of Neuroscience (DINOGMI), University of Genoa, Genoa, Italy; Clinica Neurologica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. · UC Davis Department of Neurology, Center for Neuroscience, Davis, CA, USA. · Gladstone Institute of Neurological Disease, San Francisco, CA, USA. · Department of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland. · IRCCS San Raffaele Pisana, Rome, Italy. · RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan; Graduate School of Education, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan; Advanced Center for Computing and Communication, RIKEN, 2-1 Hirosawa, Wako 351-0198, Saitama, Japan; Faculty of Physics, The University of Warsaw, Pasteur 5, 02-093 Warsaw, Poland. · A. I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland. · German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic and Psychotherapeutic Medicine, University of Rostock, Rostock, Germany. · Experimental Neuropsychopharmacology, Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM), Bonn, Germany. · Department of Neurosciences and Department of Neurology, Dokuz Eylül University Medical School, Izmir, Turkey. · Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA. · Janssen Research & Development, Janssen Pharmaceutica NV, Beerse, Belgium. · Vertex Pharmaceuticals Incorporated, Boston, MA, USA. · Pubmed 31739167
2017
  • Department of Clinical Neurophysiology and MEG, VUmc, Amsterdam, The Netherlands. · Alzheimer Center and Department of Neurology, VUmc, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Pubmed 28938009
2012
  • Department of Clinical Neurophysiology and MEG, VU University Medical Center, Amsterdam, The Netherlands. · Pubmed 22915996
  • Department of Clinical Neurophysiology and Magnetoencephalography, VU University Medical Center, Amsterdam, The Netherlands. · Pubmed 22480296
2013
  • Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands. · Pubmed 23541878
  • Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Research, VU University Amsterdam Amsterdam, Netherlands. · Pubmed 24106478
  • Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands. · Pubmed 23587637
  • Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands. · Pubmed 23536835
2012
  • Alzheimer Center, Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands. · Pubmed 22118944
Yearly article counts 20010004300
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.